Gut microbiome differences in youth with perinatally acquired HIV and fatty liver disease: a multicentre study
This multicentre study reveals that while HIV infection significantly alters gut microbiome diversity and composition in youth, the presence of metabolic dysfunction-associated fatty liver disease (MAFLD) is associated with only modest microbial changes, specifically reduced *Parabacteroides* abundance, highlighting the dominant influence of HIV on the gut-liver axis in this population.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside the human body, a vast and complex community of microscopic organisms lives in the gut, working alongside us to digest food and regulate our health. Scientists have long known that when this community becomes unbalanced, a condition called dysbiosis, it can contribute to serious metabolic problems, including a liver condition known as metabolic dysfunction-associated fatty liver disease. This liver issue, which involves the buildup of fat in the organ, is becoming increasingly common in children and young adults, often linked to rising rates of obesity. However, a specific group of young people faces a unique challenge: those who were born with HIV. Even with modern medication that keeps the virus under control, these individuals often develop fatty liver disease at higher rates than their peers, and sometimes without the usual risk factors like excess weight. This has left researchers wondering whether the virus itself, or the lifelong treatment required to manage it, might be altering the gut bacteria in a way that harms the liver, creating a hidden pathway to disease that goes beyond simple diet or weight.
To untangle this mystery, a team of researchers across Spain conducted a detailed study involving eighty-six young people, half of whom were living with perinatally acquired HIV and half of whom were uninfected. The group included individuals with and without fatty liver disease, allowing the scientists to compare how the gut microbiome differed between these groups. The researchers collected stool samples from each participant and used advanced sequencing technology to read the genetic code of the bacteria present, essentially taking a census of the microbial community. They looked not only at how many different types of bacteria were present but also at which specific species were thriving or struggling, and what metabolic jobs these bacteria were predicted to be performing. By carefully matching participants by age and gender and adjusting for factors like body weight, the team aimed to isolate the specific influence of the HIV infection from the influence of the liver disease itself.
The results revealed a clear and dominant pattern: the presence of HIV infection was the primary force shaping the gut microbiome, far more so than the presence of fatty liver disease. Young people living with HIV showed a distinct reduction in the variety of bacteria in their guts and a significant shift in the types of species present compared to their uninfected peers. The researchers found that the viral infection was associated with a coordinated restructuring of the entire microbial ecosystem, where certain beneficial groups of bacteria were depleted while others expanded. In contrast, when the scientists looked specifically at the young people with HIV who also had fatty liver disease, the differences in their gut bacteria were much more subtle. While the overall diversity of bacteria remained similar to those without liver disease, there were small, specific changes, such as a lower abundance of a particular group of bacteria called Parabacteroides, which plays a role in maintaining the gut barrier and processing fats.
These findings suggest that the gut environment in young people with HIV is fundamentally altered by the virus and its treatment, creating a background of microbial imbalance that may overshadow the smaller changes typically caused by fatty liver disease. The study indicates that when investigating liver problems in this specific population, researchers must first account for the profound impact of HIV on the gut, as this effect is the major driver of microbial change. While the study did not find a massive, unique bacterial signature for fatty liver disease within the HIV-positive group, the small differences observed, particularly the drop in Parabacteroides, offer a potential clue for future investigation. The work highlights that the path to liver disease in these young people is likely complex, involving a lifelong interaction between the virus, the immune system, and the gut ecosystem, rather than being driven solely by traditional metabolic factors like obesity.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.